This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish (read more).

Resources - Whitepapers

Drug Serialization — Local Knowledge The Key To Protecting Patients In U.S. And International Markets

Evolving track-and-trace rules in key markets are driving pharmaceutical industry demand for adaptable contractors with regional expertise, according to Ian Parsonage, Senior Director, Global Serialization Services at PCI Pharma Services.

Beginning in late November 2017, pharmaceuticals sold in the U.S. must be marked with a National Drug Code (NDC), a serial number, a lot number, and an expiration date. The requirement, stipulated in 2013’s Drug Quality and Security Act (DQSA) (H.R. 3204), is designed to harmonize existing state-to-state variations in track-and-trace laws.

Drug Serialization

December 20, 2016

PCI Clinical Services to Showcase Expertise in Phase I Clinical Trials in Australia

PCI will showcase our expertise in Phase I Clinical Trials in Australia with a series of West Coast US seminars... View Article

Success at Aspire Blaenau Gwent Shared Apprenticeship Awards

PCI is celebrating two wins in the Aspire Blaenau Gwent Shared Apprenticeship Program Awards 2018. PCI as an organization and... View Article